Detection and Management of Protein Aggregation during Downstream Processing

Abstract Protein aggregation is not only a challenge in the development of biopharmaceutical drug products (DP), it is a significant barrier to cost-effective production of purified drug substance (DS). The goal of this article is to give an example of how protein aggregation affects bioprocess deve...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter and WEBINAR UPDATES

We will not sell or give your information to a third party. See our Privacy Policy